3-bromo-4-[4-[(4-chloro-3-fluorophenyl)-(2-pyrrolidin-1-ylethoxy)methyl]piperidin-1-yl]-2H-pyrazolo[3,4-d]pyrimidine

C23H27BrClFN6O — CID 66696876

IUPAC3-bromo-4-[4-[(4-chloro-3-fluorophenyl)-(2-pyrrolidin-1-ylethoxy)methyl]piperidin-1-yl]-2H-pyrazolo[3,4-d]pyrimidine
SMILESFc1cc(C(OCCN2CCCC2)C2CCN(c3ncnc4n[nH]c(Br)c34)CC2)ccc1Cl
InChIInChI=1S/C23H27BrClFN6O/c24-21-19-22(30-29-21)27-14-28-23(19)32-9-5-15(6-10-32)20(16-3-4-17(25)18(26)13-16)33-12-11-31-7-1-2-8-31/h3-4,13-15,20H,1-2,5-12H2,(H,27,28,29,30)
InChIKeyJHOISCNSZOEUAW-UHFFFAOYSA-N
MW537.87 g/mol
LogP4.98
Rot. Bonds7

About 3-bromo-4-[4-[(4-chloro-3-fluorophenyl)-(2-pyrrolidin-1-ylethoxy)methyl]piperidin-1-yl]-2H-pyrazolo[3,4-d]pyrimidine

3-bromo-4-[4-[(4-chloro-3-fluorophenyl)-(2-pyrrolidin-1-ylethoxy)methyl]piperidin-1-yl]-2H-pyrazolo[3,4-d]pyrimidine (PubChem CID 66696876) has the molecular formula C23H27BrClFN6O and a molecular weight of 537.87 g/mol. Its IUPAC name is 3-bromo-4-[4-[(4-chloro-3-fluorophenyl)-(2-pyrrolidin-1-ylethoxy)methyl]piperidin-1-yl]-2H-pyrazolo[3,4-d]pyrimidine.

Molecular Properties

Compound Name3-bromo-4-[4-[(4-chloro-3-fluorophenyl)-(2-pyrrolidin-1-ylethoxy)methyl]piperidin-1-yl]-2H-pyrazolo[3,4-d]pyrimidine
PubChem CID66696876
Molecular FormulaC23H27BrClFN6O
Molecular Weight537.87 g/mol
Exact Mass536.11
IUPAC Name3-bromo-4-[4-[(4-chloro-3-fluorophenyl)-(2-pyrrolidin-1-ylethoxy)methyl]piperidin-1-yl]-2H-pyrazolo[3,4-d]pyrimidine
SMILESFc1cc(C(OCCN2CCCC2)C2CCN(c3ncnc4n[nH]c(Br)c34)CC2)ccc1Cl
InChIInChI=1S/C23H27BrClFN6O/c24-21-19-22(30-29-21)27-14-28-23(19)32-9-5-15(6-10-32)20(16-3-4-17(25)18(26)13-16)33-12-11-31-7-1-2-8-31/h3-4,13-15,20H,1-2,5-12H2,(H,27,28,29,30)
InChIKeyJHOISCNSZOEUAW-UHFFFAOYSA-N
XLogP4.98
TPSA70.17 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms33
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500537.87
LogP ≤ 54.98
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze 3-bromo-4-[4-[(4-chloro-3-fluorophenyl)-(2-pyrrolidin-1-ylethoxy)methyl]piperidin-1-yl]-2H-pyrazolo[3,4-d]pyrimidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-bromo-4-[4-[(4-chloro-3-fluorophenyl)-(2-pyrrolidin-1-ylethoxy)methyl]piperidin-1-yl]-2H-pyrazolo[3,4-d]pyrimidine?
The IUPAC name of 3-bromo-4-[4-[(4-chloro-3-fluorophenyl)-(2-pyrrolidin-1-ylethoxy)methyl]piperidin-1-yl]-2H-pyrazolo[3,4-d]pyrimidine (CID 66696876) is 3-bromo-4-[4-[(4-chloro-3-fluorophenyl)-(2-pyrrolidin-1-ylethoxy)methyl]piperidin-1-yl]-2H-pyrazolo[3,4-d]pyrimidine.
What is the SMILES notation for 3-bromo-4-[4-[(4-chloro-3-fluorophenyl)-(2-pyrrolidin-1-ylethoxy)methyl]piperidin-1-yl]-2H-pyrazolo[3,4-d]pyrimidine?
The canonical SMILES for 3-bromo-4-[4-[(4-chloro-3-fluorophenyl)-(2-pyrrolidin-1-ylethoxy)methyl]piperidin-1-yl]-2H-pyrazolo[3,4-d]pyrimidine is Fc1cc(C(OCCN2CCCC2)C2CCN(c3ncnc4n[nH]c(Br)c34)CC2)ccc1Cl.
What is the InChIKey of 3-bromo-4-[4-[(4-chloro-3-fluorophenyl)-(2-pyrrolidin-1-ylethoxy)methyl]piperidin-1-yl]-2H-pyrazolo[3,4-d]pyrimidine?
The InChIKey is JHOISCNSZOEUAW-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H27BrClFN6O/c24-21-19-22(30-29-21)27-14-28-23(19)32-9-5-15(6-10-32)20(16-3-4-17(25)18(26)13-16)33-12-11-31-7-1-2-8-31/h3-4,13-15,20H,1-2,5-12H2,(H,27,28,29,30).
What are the key properties of 3-bromo-4-[4-[(4-chloro-3-fluorophenyl)-(2-pyrrolidin-1-ylethoxy)methyl]piperidin-1-yl]-2H-pyrazolo[3,4-d]pyrimidine?
3-bromo-4-[4-[(4-chloro-3-fluorophenyl)-(2-pyrrolidin-1-ylethoxy)methyl]piperidin-1-yl]-2H-pyrazolo[3,4-d]pyrimidine has a molecular weight of 537.87 g/mol, XLogP of 4.98, 7 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 3-bromo-4-[4-[(4-chloro-3-fluorophenyl)-(2-pyrrolidin-1-ylethoxy)methyl]piperidin-1-yl]-2H-pyrazolo[3,4-d]pyrimidine is sourced from PubChem (CID 66696876), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).